TAIPEI, TAIWAN; – May 20, 2021 – iXensor Co., Ltd. (6734.TWO) Dr. Carson Chen, CEO of iXensor, today participated in Johnson & Johnson Innovation’s webinar “The Future of Pandemic Prevention: Innovation Ecosystem Collaboration” together with renowned experts including Rick Bright (SVP Pandemic Prevention and Response at Rockefeller Foundation, former director…
iXensor, the pioneer of mobile health, is set to launch its end-to-end digital COVID-19 rapid antigen test solution that digitizes the entire user journey from screening, reporting to access control to combat outbreaks. The clinical performance evaluation has demonstrated superior accuracy of the PixoTest® POCT COVID-19 Antigen Test. The test…
While the current COVID-19 pandemic keeps impacting us globally, this will hardly have been the last pandemic of our times. What can we do to be better prepared or even prevent it from happening, though? Join our CEO, Dr. Carson Chen, as he discusses this timely topic together with other…
While most major economies continue to strive against rising infections and deaths caused by the novel coronavirus, Taiwan has set itself up for an economic revival due to its successful pandemic control measures. The CEO of iXensor,Carson Chen, invited by the Society for Promotion of East West Knowledge Transfer, gave…
iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of…
iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources. Johnson Innovation…
TAIPEI, TAIWAN / SINGAPORE – November 25th, 2020 – iXensor Co., Ltd. (6734.TWO) Backed by two pharmaceutical giants Roche, Sanofi and organized by Plug and Play, the Startup Creasphere Program selected iXensor to join its three-month digital health accelerator program, which aimed for transforming healthcare together. In this first…
At the 3rd International Conference on Deficiency of Adenosine Deaminase 2 (DADA2), the CEO of iXensor, Dr. Carson Chen, speaks about XLab and its applications in realizing remote collaboration of developing accessible and affordable DADA2 diagnostic test with test strip developers across the globe. Dr. Carson Chen encountered the CEO…
PixoTest® is among the fastest COVID-19 antigen tests for smarter pandemic management, detecting positive SARS-CoV-2 infection cases in as short as five minutes. The PixoTest® POCT Analyzer offers prompt, accurate, and objective results through the standardized analysis of the rapid tests. PixoHealth Pass App is positioned as the digital screening tool…
TAIPEI, TAIWAN – May 18th, 2020 – iXensor Co., Ltd. (6734.TWO). On February 21st, 2020, iXensor formed the COMBAT project team to tackle the global COVID-19 pandemic challenge from the testing and digital solution perspective, aiming to aid the early detection of COVID-19 infections. Two state-of-the-art antigen-based testing solutions are…
